RMD - ResMed Inc.
After hours:
| Previous close | 220.64 |
| Open | 219.79 |
| Bid | 220.00 x 800 |
| Ask | 227.07 x 800 |
| Day's range | 219.97 - 222.45 |
| 52-week range | 194.30 - 247.65 |
| Volume | |
| Avg. volume | 596,030 |
| Market cap | 32.636B |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 37.90 |
| EPS (TTM) | 5.86 |
| Earnings date | 09 Aug 2023 - 14 Aug 2023 |
| Forward dividend & yield | 1.76 (0.79%) |
| Ex-dividend date | 10 May 2023 |
| 1y target est | 260.75 |
ZacksZBH vs. RMD: Which Stock Should Value Investors Buy Now?
ZBH vs. RMD: Which Stock Is the Better Value Option?
Simply Wall St.ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company
Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their...
- Simply Wall St.
With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
ZacksResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.
ZacksResMed (RMD) Q3 Earnings and Revenues Beat Estimates
ResMed (RMD) delivered earnings and revenue surprises of 7.01% and 7.95%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
ResMed Inc.'s (NYSE:RMD) Stock Been Rising: Are Strong Financials Guiding The Market?
ResMed's (NYSE:RMD) stock up by 7.8% over the past three months. Given that the market rewards strong financials in the...
Motley Fool3 Incredible Growth Stocks to Buy Right Now
U.S. stock markets are going through an unusually volatile period, thanks to the uncertainty posed by the global banking crisis and the Federal Reserve's plan for interest rates. While wild price swings can be nerve-racking for shareholders, choppy markets can also be a great time to pick up shares of top companies at significant discounts to their intrinsic value. Which growth stocks are on watch for a possible entry point?
ZacksReasons Why You Should Retain ResMed (RMD) Stock For Now
Investors are optimistic about ResMed's (RMD) Increased demand for its digital health solution.
ZacksEYE vs. RMD: Which Stock Should Value Investors Buy Now?
EYE vs. RMD: Which Stock Is the Better Value Option?
- Simply Wall St.
Is ResMed Inc. (NYSE:RMD) Worth US$216 Based On Its Intrinsic Value?
Key Insights ResMed's estimated fair value is US$178 based on 2 Stage Free Cash Flow to Equity ResMed is estimated to...
ZacksTop Research Reports for Chevron, Novo Nordisk & Amgen
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).
- Zacks
ResMed's (RMD) Mask Sales Drive Growth, Margin Issue Lingers
ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.
- Simply Wall St.
ResMed Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS In Line
ResMed ( NYSE:RMD ) Second Quarter 2023 Results Key Financial Results Revenue: US$1.03b (up 16% from 2Q 2022). Net...
ZacksESLOY vs. RMD: Which Stock Is the Better Value Option?
ESLOY vs. RMD: Which Stock Is the Better Value Option?
ZacksResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
ResMed's (RMD) mask sales growth was strong across the globe, reflecting a post-COVID pandemic awareness about the importance and need for respiratory hygiene and respiratory health.
ZacksResMed (RMD) Q2 Earnings and Revenues Surpass Estimates
ResMed (RMD) delivered earnings and revenue surprises of 3.75% and 3.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
ResMed's (NYSE:RMD) 21% CAGR outpaced the company's earnings growth over the same five-year period
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...
ZacksThe Zacks Analyst Blog Highlights Home Depot, Merck, Bank of America, Elevance Health and ResMed
Home Depot, Merck, Bank of America, Elevance Health and ResMed are included in this Analyst Blog.
ZacksTop Analyst Reports for Home Depot, Merck & Bank of America
Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Merck & Co., Inc. (MRK) and Bank of America Corporation (BAC).
- Simply Wall St.
Shareholders Would Enjoy A Repeat Of ResMed's (NYSE:RMD) Recent Growth In Returns
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
- Simply Wall St.
ResMed Inc.'s (NYSE:RMD) recent 3.5% pullback adds to one-year year losses, institutional owners may take drastic measures
A look at the shareholders of ResMed Inc. ( NYSE:RMD ) can tell us which group is most powerful. We can see that...
- Simply Wall St.
Here's Why Shareholders Will Not Be Complaining About ResMed Inc.'s (NYSE:RMD) CEO Pay Packet
It would be hard to discount the role that CEO Mick Farrell has played in delivering the impressive results at ResMed...
ZacksResMed (RMD) Q1 Earnings In Line, Operating Margin Falls
ResMed (RMD) continues to increase its access to semiconductor communications chips.
Motley FoolCompany Report Roundup: Tesla, Tractor Supply, American Express, and More
In this podcast, Motley Fool senior analysts Emily Flippen and Ron Gross discuss topics including: Pinterest, Meta Platforms, and Alphabet getting dragged down by Snap's bad news American Express shares ...
- Simply Wall St.
Is ResMed Inc.'s (NYSE:RMD) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Most readers would already be aware that ResMed's (NYSE:RMD) stock increased significantly by 9.4% over the past month...
